Research Guides
Reference material on the compounds in our catalogue — receptor pharmacology, how the compound classes relate to each other, and the analytical practice behind batch documentation. Written for laboratory context, without therapeutic framing.
Tirzepatide vs Semaglutide: a pharmacology comparison
How a dual GIP/GLP-1 agonist differs from a single GLP-1 agonist — receptor targets, molecular design, half-life and the trial programmes behind each compound.
Retatrutide: what the triple-agonist data actually shows
Retatrutide (LY3437943) engages three receptors rather than one or two. What the glucagon receptor adds, and what the published phase 2 data established.
The incretin compound classes, explained
Mono-, dual- and triple-agonists, amylin analogues and oral formulations — how the metabolic research catalogue is organised and what separates each class.
How to read a Certificate of Analysis
What each section of a COA establishes, which figures matter, and the checks that separate a meaningful certificate from a decorative one.